Domestic pharmaceutical firms promoting aggressive new products marketing

Published: 2003-08-13 07:00:00

Updated: 2003-08-13 07:00:00

Facing sluggish pharmaceutical sales in the first half of this year amid serious business downturn in Korea, a number of pharmaceutical firms are concentrating their efforts to boost their sales revenue via new product launchings.

Pharmaceutical business sources say that with the prevailing pe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK